Taxonomic and Genomic Characterization of Brevibacillus sp. JNUCC 42 from Baengnokdam Crater Lake, Mt. Halla, and Its Cosmeceutical Potential

Jeju Island, a volcanic island located off the southern coast of the Korean Peninsula, harbors highly specialized microbial communities shaped by its unique geological and climatic diversity. In particular, Baengnokdam Crater Lake at the summit of Mt. Halla represents an extreme, oligotrophic volcanic habitat characterized by intense UV radiation, temperature fluctuations, and limited nutrients. From this environment, a novel bacterial strain, Brevibacillus sp. JNUCC 42, was isolated and subjected to comprehensive taxonomic, genomic, and biochemical analyses. The strain is a Gram-positive, aerobic, rod-shaped bacterium that grows optimally at 30 °C and pH 7.0–9.0 with moderate NaCl tolerance (≤3%). Phylogenetic analysis based on 16S rRNA gene sequencing and genome-scale GBDP confirmed its affiliation to the genus Brevibacillus, forming a distinct lineage closely related to B. laterosporus DSM 25T. Whole-genome sequencing generated a 4.93 Mb circular chromosome with a GC content of 40.7%. Comparative genomic analyses revealed ANI (87.1%) and dDDH (32.8%) values far below the species threshold, supporting its delineation as a novel species. Chemotaxonomic data further distinguished JNUCC 42 by its predominance of anteiso-C15:0 (37.24%) and iso-C15:0 (27.78%) fatty acids and the presence of a unique unidentified aminolipid not detected in the type strain. Genome mining identified 21 biosynthetic gene clusters, including NRPS, PKS, and NRPS–PKS hybrids, suggesting its potential to produce structurally diverse secondary metabolites. One of these metabolites, the cyclic dipeptide maculosin [cyclo(L-Pro-L-Tyr)], was purified from the culture extract and structurally characterized by NMR spectroscopy. Functional assays demonstrated that maculosin significantly inhibited α-MSH-induced melanogenesis and intracellular tyrosinase activity in B16F10 melanoma cells without cytotoxicity up to 100 µM. Collectively, these findings indicate that Brevibacillus sp. JNUCC 42 represents a novel species within the genus Brevibacillus and a promising microbial source of bioactive compounds with potential cosmeceutical applications.